These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9652765)

  • 1. Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalation.
    Mackean MJ; Cassidy J; Jodrell DI; Paul J; Reed NS; Canney PA; Yosef H; Habeshaw T; Robertson AG; McInnes A; Twelves CJ
    Br J Cancer; 1998 May; 77(9):1480-6. PubMed ID: 9652765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
    Streit M; Jaehde U; Stremetzne S; Ridwelski K; Kerz H; Strohbach F; Hohenberger P; Zwiebel FM; Hebart H; Böthig R; Kairies M; Zillig D; Schuchmann S; Warnecke S; Thiel E; Kreuser ED
    Ann Oncol; 1997 Nov; 8(11):163-5. PubMed ID: 9426339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial of weekly infusional 5-fluorouracil in combination with low-dose leucovorin in patients with advanced colorectal cancer.
    Haas NB; Schilder RJ; Nash S; Weiner LM; Catalano RC; Ozols RF; O'Dwyer PJ
    Invest New Drugs; 1995; 13(3):229-33. PubMed ID: 8729951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
    Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
    Aranda E; Cervantes A; Carrato A; Antón-Torres A; Massutí T; Fernández-Martos C; Díaz-Rubio E
    J Infus Chemother; 1996; 6(3):118-22. PubMed ID: 9229321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
    Klaassen U; Wilke H; Seeber S
    J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
    Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma.
    Grem JL; McAtee N; Balis F; Murphy R; Venzon D; Kramer B; Goldspiel B; Begley M; Allegra CJ
    Cancer; 1993 Aug; 72(3):663-8. PubMed ID: 8334622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY
    Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
    Hartmann JT; Köhne CH; Schmoll HJ; Daikeler T; Kanz L; Bokemeyer C
    Oncology; 1998; 55(4):320-5. PubMed ID: 9663421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer.
    Hejna M; Kornek GV; Raderer M; Depisch D; Brodowicz T; Fiebiger WC; Scheithauer W
    Br J Cancer; 1998 Sep; 78(6):760-4. PubMed ID: 9743296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bolus/infusional 5-fluorouracil and folinic acid for metastatic colorectal carcinoma: are suboptimal dosages being used in the UK?
    Jodrell DI; Murray LS; Reed NS; Canney PA; Kaye SB; Cassidy J
    Br J Cancer; 1994 Oct; 70(4):749-52. PubMed ID: 7917933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer.
    Garufi C; Lévi F; Aschelter AM; Pace R; Giunta S; Nisticò C; Gallà DA; Silecchia GF; Franchi F; Narduzzi C; Terzoli E
    Eur J Cancer; 1997 Sep; 33(10):1566-71. PubMed ID: 9389916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas.
    Chen JS; Jan YY; Lin YC; Wang HM; Chang WC; Liau CT
    Anticancer Drugs; 1998 Jun; 9(5):393-7. PubMed ID: 9660535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies.
    André T; Colin P; Louvet C; Gamelin E; Bouche O; Achille E; Colbert N; Boaziz C; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Billiau V; Buyse M; Gramont A;
    Semin Oncol; 2001 Feb; 28(1 Suppl 1):35-40. PubMed ID: 11273588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer.
    Ducreux M; Ychou M; Seitz JF; Bonnay M; Bexon A; Armand JP; Mahjoubi M; Méry-Mignard D; Rougier P
    J Clin Oncol; 1999 Sep; 17(9):2901-8. PubMed ID: 10561369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patient with colorectal carcinoma.
    Meropol NJ; Petrelli NJ; Rustum YM; Rodriguez-Bigas M; Blumenson LE; Frank C; Berghorn E; Creaven PJ
    Invest New Drugs; 1995; 13(2):149-55. PubMed ID: 8617578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
    Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.